Shorter treatment for mild spinal TB
Treatments studied
Part of Bones, joints & muscles, Infections clinical trials.
This trial tests a shorter course of antibiotics for people with mild spinal tuberculosis. It aims to see if a shorter treatment works just as well as the standard longer course, which could mean fewer side effects and a quicker recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You have been diagnosed with mild spinal tuberculosis (TB in the spine).
- You are not pregnant or breastfeeding, and you agree to use birth control during the study.
- You can take medications by mouth.
- You have not had more than 5 days of TB treatment in the last 6 months, and your TB bacteria are not resistant to key drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a shorter, rifampicin-based treatment works well for people with less severe TB in the lungs. If you have limited TB that is sensitive to rifampicin, you might be able to take medicine for a shorter time than usual.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This trial studies whether a rifapentine-based TB regimen can work just as well while shortening treatment time. It’s for people with rifampicin-sensitive, smear-positive lung tuberculosis.
This trial tests if a shorter treatment course works as well as the standard one for people whose chest X-rays suggest TB but whose sputum tests are negative. It aims to make treatment easier for patients.
This trial tests whether you can take a shorter course of standard treatment for drug-sensitive pulmonary (lung) tuberculosis by using a higher dose of rifampicin. It may help some people finish treatment sooner, while doctors track how well the infection clears.
This study is testing whether a shorter course of TB medicine works just as well as the standard longer treatment for children with drug-susceptible tuberculosis. It aims to make treatment easier for families.
Hear when a new Mild Spinal Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.